Yoshiya Tanaka
发表论文 18 篇 · 总被引 72 次 · h-index 5
代表论文
- Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update. (2025 · Annals of the Rheumatic Diseases · 被引 32)
- Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases-a systematic literature review informing the 2024 update of an international expert consensus statement. (2025 · Annals of the Rheumatic Diseases · 被引 20)
- Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases-a systematic literature review informing the 2024 update of an international expert consensus statement. (2025 · Annals of the Rheumatic Diseases · 被引 18)
- OP0035 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate (2018 · WEDNESDAY, 13 JUNE 2018 · 被引 11)
- Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes (2025 · RMD Open · 被引 10)
- Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort (2025 · Arthritis Research & Therapy · 被引 5)